vs

Side-by-side financial comparison of Chanson International Holding (CHSN) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.

Sol-Gel Technologies Ltd. is the larger business by last-quarter revenue ($17.3M vs $8.7M, roughly 2.0× Chanson International Holding). Sol-Gel Technologies Ltd. runs the higher net margin — 67.3% vs -12.1%, a 79.3% gap on every dollar of revenue. On growth, Sol-Gel Technologies Ltd. posted the faster year-over-year revenue change (217.7% vs 15.2%).

Chanson International Holding is a food and beverage enterprise focused on operating premium bakery chains primarily across mainland China. Its product portfolio includes freshly baked bread, handcrafted pastries, custom celebration cakes, specialty beverages, and frozen bakery goods supplied to partnered retail outlets, catering to middle-class consumers with demand for high-quality daily food options.

Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.

CHSN vs SLGL — Head-to-Head

Bigger by revenue
SLGL
SLGL
2.0× larger
SLGL
$17.3M
$8.7M
CHSN
Growing faster (revenue YoY)
SLGL
SLGL
+202.5% gap
SLGL
217.7%
15.2%
CHSN
Higher net margin
SLGL
SLGL
79.3% more per $
SLGL
67.3%
-12.1%
CHSN

Income Statement — Q2 FY2025 vs Q2 FY2025

Metric
CHSN
CHSN
SLGL
SLGL
Revenue
$8.7M
$17.3M
Net Profit
$-1.0M
$11.6M
Gross Margin
44.5%
Operating Margin
-13.7%
65.1%
Net Margin
-12.1%
67.3%
Revenue YoY
15.2%
217.7%
Net Profit YoY
-4579.7%
487.6%
EPS (diluted)
$-2.87
$4.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHSN
CHSN
SLGL
SLGL
Q2 25
$8.7M
$17.3M
Q2 24
$7.5M
$5.4M
Q2 23
$594.0K
Q2 22
$3.5M
Net Profit
CHSN
CHSN
SLGL
SLGL
Q2 25
$-1.0M
$11.6M
Q2 24
$23.4K
$2.0M
Q2 23
$-6.0M
Q2 22
$-134.0K
Gross Margin
CHSN
CHSN
SLGL
SLGL
Q2 25
44.5%
Q2 24
41.5%
Q2 23
Q2 22
Operating Margin
CHSN
CHSN
SLGL
SLGL
Q2 25
-13.7%
65.1%
Q2 24
-7.4%
29.9%
Q2 23
-1098.8%
Q2 22
-13.2%
Net Margin
CHSN
CHSN
SLGL
SLGL
Q2 25
-12.1%
67.3%
Q2 24
0.3%
36.4%
Q2 23
-1005.1%
Q2 22
-3.8%
EPS (diluted)
CHSN
CHSN
SLGL
SLGL
Q2 25
$-2.87
$4.17
Q2 24
$0.15
$0.71
Q2 23
$-0.22
Q2 22
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHSN
CHSN
SLGL
SLGL
Cash + ST InvestmentsLiquidity on hand
$22.1M
$24.3M
Total DebtLower is stronger
$4.5M
Stockholders' EquityBook value
$24.5M
$31.9M
Total Assets
$51.6M
$39.3M
Debt / EquityLower = less leverage
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHSN
CHSN
SLGL
SLGL
Q2 25
$22.1M
$24.3M
Q2 24
$4.1M
$26.5M
Q2 23
$33.5M
Q2 22
$15.6M
Total Debt
CHSN
CHSN
SLGL
SLGL
Q2 25
$4.5M
Q2 24
Q2 23
Q2 22
Stockholders' Equity
CHSN
CHSN
SLGL
SLGL
Q2 25
$24.5M
$31.9M
Q2 24
$12.1M
$34.9M
Q2 23
$48.3M
Q2 22
$50.4M
Total Assets
CHSN
CHSN
SLGL
SLGL
Q2 25
$51.6M
$39.3M
Q2 24
$38.7M
$42.0M
Q2 23
$55.1M
Q2 22
$55.0M
Debt / Equity
CHSN
CHSN
SLGL
SLGL
Q2 25
0.18×
Q2 24
Q2 23
Q2 22

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHSN
CHSN
SLGL
SLGL
Operating Cash FlowLast quarter
$-390.3K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHSN
CHSN
SLGL
SLGL
Q2 25
$-390.3K
Q2 24
$806.1K
Q2 23
$-8.3M
Q2 22
Free Cash Flow
CHSN
CHSN
SLGL
SLGL
Q2 25
Q2 24
$771.9K
Q2 23
$-8.4M
Q2 22
FCF Margin
CHSN
CHSN
SLGL
SLGL
Q2 25
Q2 24
10.2%
Q2 23
-1419.0%
Q2 22
Capex Intensity
CHSN
CHSN
SLGL
SLGL
Q2 25
Q2 24
0.5%
Q2 23
15.8%
Q2 22
Cash Conversion
CHSN
CHSN
SLGL
SLGL
Q2 25
Q2 24
34.43×
Q2 23
Q2 22

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons